Sessa Capital (Master), L.P. - 31 Mar 2023 Form 4 Insider Report for Provention Bio, Inc.

Role
10%+ Owner
Signature
/s/ John Petry, for Sessa Capital (Master), L.P., By: Sessa Capital GP, LLC, its general partner, By: John Petry, as manager
Issuer symbol
N/A
Transactions as of
31 Mar 2023
Net transactions value
$0
Form type
4
Filing time
04 Apr 2023, 20:10:45 UTC
Previous filing
20 Jan 2023
Next filing
18 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVB Common Stock Other $0 -3,000,000 -25% $0.000000 8,879,023 31 Mar 2023 Direct F1, F2
transaction PRVB Common Stock Gift $0 -218,651 -34% $0.000000 426,931 04 Apr 2023 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sessa Capital (Master), L.P. distributed these shares to its partners on a pro rata basis, for no consideration.
F2 These securities of Provention Bio, Inc. are beneficially owned by (i) Sessa Capital (Master), L.P. (the "Fund"), as a result of direct beneficial ownership of the shares, (ii) Sessa Capital GP, LLC, indirectly as a result of being the sole general partner of the Fund, (iii) Sessa Capital IM, L.P. indirectly as a result of being the investment adviser for the Fund, (iv) Sessa Capital IM GP, LLC, indirectly as a result of being the sole general partner of Sessa Capital IM, L.P., and (v) John Petry, indirectly as a result of being the manager of Sessa Capital GP, LLC and Sessa Capital IM GP, LLC. Each of the Reporting Persons and Mr. Petry disclaim beneficial ownership of any securities reported by any person except to the extent of their pecuniary interest therein.
F3 These shares of Common Stock were donated by John Petry to Fidelity Investments Charitable Gift Fund, a donor advised fund.
F4 Held directly by Mr. Petry.